PAPER Rosenthal SL, Barmada MM, Wang X, Demirci FY, Kamboh MI
SEARCH RESULTS
330986 RESULTS
PAPER Ziegler G, Ridgway GR, Dahnke R, Gaser C, Alzheimer's Disease Neuroimaging Initiative
Individualized Gaussian process-based prediction and detection of local and global gray matter abnormalities in elderly subjects.
Neuroimage. 2014 Aug 15;97:333-48. Epub 2014 Apr 15 PubMed: 24742919PAPER Elobeid A, Rantakömi S, Soininen H, Alafuzoff I
Alzheimer's disease-related plaques in nondemented subjects.
Alzheimers Dement. 2014 Sep;10(5):522-9. Epub 2014 Apr 16 PubMed: 24742915PAPER Gao F, Barker PB
Various MRS application tools for Alzheimer disease and mild cognitive impairment.
AJNR Am J Neuroradiol. 2014 Jun;35(6 Suppl):S4-11. Epub 2014 Apr 17 PubMed: 24742809PAPER Chen DL, Zhang P, Lin L, Zhang HM, Deng SD, Wu ZQ, Ou S, Liu SH, Wang JY
Protective effects of bajijiasu in a rat model of Aβ₂₅₋₃₅-induced neurotoxicity.
J Ethnopharmacol. 2014 May 28;154(1):206-17. Epub 2014 Apr 14 PubMed: 24742752PAPER Sullivan SE, Dillon GM, Sullivan JM, Ho A
Mint proteins are required for synaptic activity-dependent amyloid precursor protein (APP) trafficking and amyloid β generation.
J Biol Chem. 2014 May 30;289(22):15374-83. Epub 2014 Apr 17 PubMed: 24742670PAPER Doty RL, Bayona EA, Leon-Ariza DS, Cuadros J, Chung I, Vazquez B, Leon-Sarmiento FE
The lateralized smell test for detecting Alzheimer's disease: failure to replicate.
J Neurol Sci. 2014 May 15;340(1-2):170-3. Epub 2014 Mar 19 PubMed: 24742666PAPER Parsons MP, Raymond LA
Extrasynaptic NMDA receptor involvement in central nervous system disorders.
Neuron. 2014 Apr 16;82(2):279-93. PubMed: 24742457PAPER Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN
Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.
Neuron. 2014 Apr 16;82(2):380-97. PubMed: 24742461PAPER Dixon RA, de Frias CM
Cognitively elite, cognitively normal, and cognitively impaired aging: neurocognitive status and stability moderate memory performance.
J Clin Exp Neuropsychol. 2014;36(4):418-30. Epub 2014 Apr 17 PubMed: 24742143PAPER Burbulla LF, Fitzgerald JC, Stegen K, Westermeier J, Thost AK, Kato H, Mokranjac D, Sauerwald J, Martins LM, Woitalla D, Rapaport D, Riess O, Proikas-Cezanne T, Rasse TM, Krüger R
Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1.
Cell Death Dis. 2014 Apr 17;5:e1180. PubMed: 24743735PAPER McLaughlin NC, Piryatinsky I, Epstein-Lubow G, Marino L, Friedman JH
Neuropsychiatric symptoms in an inpatient Parkinson's disease sample.
Parkinsons Dis. 2014;2014:420240. Epub 2014 Mar 12 PubMed: 24744956PAPER Morley JF, Pawlowski SM, Kesari A, Maina I, Pantelyat A, Duda JE
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
Parkinsonism Relat Disord. 2014 Jul;20(7):738-42. Epub 2014 Apr 1 PubMed: 24742370Guna Rajagopal
Janssen Research and DevelopmentSpring House, United States
Olav Andersen on Could Bolstering the Retromer Thwart Alzheimer’s?
COMMENT The paper by Mecozzi et al. elegantly demonstrates how a small drug, R55, is able to stabilize the retromer complex, enabling enhanced neuronal transport of APP (and sorLA) out of early endosomal compartments thereby escaping amyloidogenic processing. The
Current Filters
No filters selected